118 related articles for article (PubMed ID: 8969980)
1. Etrank: a ranking procedure for handling missing data in clinical trials: application to venlafaxine extended-release depression clinical trial.
Entsuah R
J Biopharm Stat; 1996 Nov; 6(4):457-75. PubMed ID: 8969980
[TBL] [Abstract][Full Text] [Related]
2. A double-blind, placebo-controlled comparison of venlafaxine and fluoxetine treatment in depressed outpatients.
Nemeroff CB; Thase ME;
J Psychiatr Res; 2007; 41(3-4):351-9. PubMed ID: 16165158
[TBL] [Abstract][Full Text] [Related]
3. Analyzing incomplete longitudinal clinical trial data.
Molenberghs G; Thijs H; Jansen I; Beunckens C; Kenward MG; Mallinckrodt C; Carroll RJ
Biostatistics; 2004 Jul; 5(3):445-64. PubMed ID: 15208205
[TBL] [Abstract][Full Text] [Related]
4. Effect of dropouts in a longitudinal study: an application of a repeated ordinal model.
Lesaffre E; Molenberghs G; Dewulf L
Stat Med; 1996 Jun; 15(11):1123-41. PubMed ID: 8804143
[TBL] [Abstract][Full Text] [Related]
5. [Treatment with venlafaxine extended release for climacteric women with depression or anxiety diagnosis. An open-label study].
Iglesias C; Pato E; Ocio S; Ortigosa JC; Santamarina S; Merino MJ; Alonso MJ; Fernández L; Alonso JL; Rodríguez L
Actas Esp Psiquiatr; 2009; 37(3):137-42. PubMed ID: 19533425
[TBL] [Abstract][Full Text] [Related]
6. Venlafaxine in depressed geriatric outpatients: an open-label clinical study.
Khan A; Rudolph R; Baumel B; Ferguson J; Ryan P; Shrivastava R
Psychopharmacol Bull; 1995; 31(4):753-8. PubMed ID: 8851649
[TBL] [Abstract][Full Text] [Related]
7. Comparing speeds of effectiveness of two treatments.
Wolfe RA; Wolfe JC; Entsuah AR
Psychopharmacol Bull; 1996; 32(3):369-75. PubMed ID: 8961780
[TBL] [Abstract][Full Text] [Related]
8. A local influence sensitivity analysis for incomplete longitudinal depression data.
Shen S; Beunckens C; Mallinckrodt C; Molenberghs G
J Biopharm Stat; 2006 May; 16(3):365-84. PubMed ID: 16724491
[TBL] [Abstract][Full Text] [Related]
9. The patient with comorbid depression and anxiety: the unmet need.
Bakish D
J Clin Psychiatry; 1999; 60 Suppl 6():20-4. PubMed ID: 10235121
[TBL] [Abstract][Full Text] [Related]
10. Venlafaxine and generalised anxiety disorder: new preparation. Minimise recourse to drugs.
Prescrire Int; 2001 Oct; 10(55):131-4. PubMed ID: 11824426
[TBL] [Abstract][Full Text] [Related]
11. Venlafaxine extended release (XR) in the treatment of generalized anxiety disorder.
Sheehan DV
J Clin Psychiatry; 1999; 60 Suppl 22():23-8. PubMed ID: 10634352
[TBL] [Abstract][Full Text] [Related]
12. Comparisons of the efficacy and tolerability of extended-release venlafaxine, mirtazapine, and paroxetine in treatment-resistant depression: a double-blind, randomized pilot study in a Chinese population.
Fang Y; Yuan C; Xu Y; Chen J; Wu Z; Cao L; Yi Z; Hong W; Wang Y; Jiang K; Gao K; Cui X; Nierenberg AA;
J Clin Psychopharmacol; 2010 Aug; 30(4):357-64. PubMed ID: 20571433
[TBL] [Abstract][Full Text] [Related]
13. Attaining remission in generalized anxiety disorder: venlafaxine extended release comparative data.
Sheehan DV
J Clin Psychiatry; 2001; 62 Suppl 19():26-31. PubMed ID: 11577788
[TBL] [Abstract][Full Text] [Related]
14. Depression in primary care: effectiveness of venlafaxine extended-release in elderly patients; Observational study.
Cervera-Enguix S; Baca-Baldomero E; Garcia-Calvo C; Prieto-López R;
Arch Gerontol Geriatr; 2004; 38(3):271-80. PubMed ID: 15066313
[TBL] [Abstract][Full Text] [Related]
15. An example of using mixed models and PROC MIXED for longitudinal data.
Wolfinger RD
J Biopharm Stat; 1997 Nov; 7(4):481-500. PubMed ID: 9358325
[TBL] [Abstract][Full Text] [Related]
16. Dual-dual action? Combining venlafaxine and mirtazapine in the treatment of depression.
Malhi GS; Ng F; Berk M
Aust N Z J Psychiatry; 2008 Apr; 42(4):346-9. PubMed ID: 18330778
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant efficacy of venlafaxine.
Golden RN; Nicholas L
Depress Anxiety; 2000; 12 Suppl 1():45-9. PubMed ID: 11098413
[TBL] [Abstract][Full Text] [Related]
18. The treatment of depression with different formulations of venlafaxine: a comparative analysis.
Olver JS; Burrows GD; Norman TR
Hum Psychopharmacol; 2004 Jan; 19(1):9-16. PubMed ID: 14716706
[TBL] [Abstract][Full Text] [Related]
19. Venlafaxine in the treatment of depressive and vasomotor symptoms in women with perimenopausal depression.
Ladd CO; Newport DJ; Ragan KA; Loughhead A; Stowe ZN
Depress Anxiety; 2005; 22(2):94-7. PubMed ID: 16094663
[TBL] [Abstract][Full Text] [Related]
20. A Randomized controlled trial of venlafaxine ER versus placebo in pediatric social anxiety disorder.
March JS; Entusah AR; Rynn M; Albano AM; Tourian KA
Biol Psychiatry; 2007 Nov; 62(10):1149-54. PubMed ID: 17553467
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
